IBDEI0HK ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8534,1,3,0)
 ;;=3^Glauc Assoc w/ Ocular Inflamm
 ;;^UTILITY(U,$J,358.3,8534,1,4,0)
 ;;=4^365.62
 ;;^UTILITY(U,$J,358.3,8534,2)
 ;;=^268777
 ;;^UTILITY(U,$J,358.3,8535,0)
 ;;=365.00^^58^610^33
 ;;^UTILITY(U,$J,358.3,8535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8535,1,3,0)
 ;;=3^Glaucoma,Suspects
 ;;^UTILITY(U,$J,358.3,8535,1,4,0)
 ;;=4^365.00
 ;;^UTILITY(U,$J,358.3,8535,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,8536,0)
 ;;=365.60^^58^610^10
 ;;^UTILITY(U,$J,358.3,8536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8536,1,3,0)
 ;;=3^Glauc w/ Unspec Ocular D/O
 ;;^UTILITY(U,$J,358.3,8536,1,4,0)
 ;;=4^365.60
 ;;^UTILITY(U,$J,358.3,8536,2)
 ;;=^268775
 ;;^UTILITY(U,$J,358.3,8537,0)
 ;;=365.9^^58^610^35
 ;;^UTILITY(U,$J,358.3,8537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8537,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,8537,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,8537,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,8538,0)
 ;;=365.22^^58^610^12
 ;;^UTILITY(U,$J,358.3,8538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8538,1,3,0)
 ;;=3^Glaucoma,Acute Angle Closure
 ;;^UTILITY(U,$J,358.3,8538,1,4,0)
 ;;=4^365.22
 ;;^UTILITY(U,$J,358.3,8538,2)
 ;;=^268754
 ;;^UTILITY(U,$J,358.3,8539,0)
 ;;=365.59^^58^610^7
 ;;^UTILITY(U,$J,358.3,8539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8539,1,3,0)
 ;;=3^Glauc Assoc w/ Lens D/O
 ;;^UTILITY(U,$J,358.3,8539,1,4,0)
 ;;=4^365.59
 ;;^UTILITY(U,$J,358.3,8539,2)
 ;;=^268773
 ;;^UTILITY(U,$J,358.3,8540,0)
 ;;=365.44^^58^610^9
 ;;^UTILITY(U,$J,358.3,8540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8540,1,3,0)
 ;;=3^Glauc Assoc w/ Systemic Syndromes
 ;;^UTILITY(U,$J,358.3,8540,1,4,0)
 ;;=4^365.44
 ;;^UTILITY(U,$J,358.3,8540,2)
 ;;=^268769
 ;;^UTILITY(U,$J,358.3,8541,0)
 ;;=377.14^^58^610^36
 ;;^UTILITY(U,$J,358.3,8541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8541,1,3,0)
 ;;=3^Glaucomatous Atrophy
 ;;^UTILITY(U,$J,358.3,8541,1,4,0)
 ;;=4^377.14
 ;;^UTILITY(U,$J,358.3,8541,2)
 ;;=^269218
 ;;^UTILITY(U,$J,358.3,8542,0)
 ;;=365.14^^58^610^15
 ;;^UTILITY(U,$J,358.3,8542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8542,1,3,0)
 ;;=3^Glaucoma,Infantile/Juv
 ;;^UTILITY(U,$J,358.3,8542,1,4,0)
 ;;=4^365.14
 ;;^UTILITY(U,$J,358.3,8542,2)
 ;;=^268750
 ;;^UTILITY(U,$J,358.3,8543,0)
 ;;=743.20^^58^610^3
 ;;^UTILITY(U,$J,358.3,8543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8543,1,3,0)
 ;;=3^Buphthalmous,Unsp w/ Oth Ocu Abnormal
 ;;^UTILITY(U,$J,358.3,8543,1,4,0)
 ;;=4^743.20
 ;;^UTILITY(U,$J,358.3,8543,2)
 ;;=^59682
 ;;^UTILITY(U,$J,358.3,8544,0)
 ;;=378.83^^58^611^3
 ;;^UTILITY(U,$J,358.3,8544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8544,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,8544,1,4,0)
 ;;=4^378.83
 ;;^UTILITY(U,$J,358.3,8544,2)
 ;;=Convergence Insufficiency^269277
 ;;^UTILITY(U,$J,358.3,8545,0)
 ;;=378.00^^58^611^5
 ;;^UTILITY(U,$J,358.3,8545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8545,1,3,0)
 ;;=3^Esotropia
 ;;^UTILITY(U,$J,358.3,8545,1,4,0)
 ;;=4^378.00
 ;;^UTILITY(U,$J,358.3,8545,2)
 ;;=Esotropia^42597
 ;;^UTILITY(U,$J,358.3,8546,0)
 ;;=378.10^^58^611^9
 ;;^UTILITY(U,$J,358.3,8546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8546,1,3,0)
 ;;=3^Exotropia
 ;;^UTILITY(U,$J,358.3,8546,1,4,0)
 ;;=4^378.10
 ;;^UTILITY(U,$J,358.3,8546,2)
 ;;=Exotropia^43741
 ;;^UTILITY(U,$J,358.3,8547,0)
 ;;=378.41^^58^611^4
 ;;^UTILITY(U,$J,358.3,8547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8547,1,3,0)
 ;;=3^Esophoria
 ;;^UTILITY(U,$J,358.3,8547,1,4,0)
 ;;=4^378.41
 ;;^UTILITY(U,$J,358.3,8547,2)
 ;;=Esophoria^265435
